What sector does Dr. Agarwal'S Eye Hosp L belong to?

Dr. Agarwal'S Eye Hosp L operates in the Healthcare sector, specifically the Hospital industry, and is listed on the NSE.

What is the current share price of DRAGARWQ?

As of the latest available quote, DRAGARWQ traded at ₹5,306.50. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of DRAGARWQ?

Dr. Agarwal'S Eye Hosp L has a price-to-earnings (P/E) ratio of about 33.45. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of DRAGARWQ?

The market capitalisation of Dr. Agarwal'S Eye Hosp L is approximately ₹2,565 Cr.

Is Dr. Agarwal'S Eye Hosp L profitable?

For its latest reported financial year, Dr. Agarwal'S Eye Hosp L recorded a net profit margin of about 14.86%.

Does DRAGARWQ pay a dividend?

Dr. Agarwal'S Eye Hosp L does not currently show a dividend yield in our data.

What is the return on equity (ROE) of DRAGARWQ?

Dr. Agarwal'S Eye Hosp L has a return on equity (ROE) of about 25.20%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of DRAGARWQ?

Over the past 52 weeks, DRAGARWQ has traded between a low of ₹5,151.00 and a high of ₹5,500.00.

Dr. Agarwal'S Eye Hosp L

DRAGARWQ NSE Healthcare Hospital

₹5,306.50

+0.01%

Delayed · cached 15 min

Fair value analysis

DRAGARWQ

Dr. Agarwal'S Eye Hosp L

₹5,306.00

Close used for this calculation

₹4,781.68Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

59/100

Profitability21/25

Returns16/25

Balance Sheet14/25

Efficiency8/25

Growth12/25

Good

Quality radar

Consensus fair value

₹4,781.68

Near FV

▼ -9.9% against the close used

Model range ₹1,595.80 – ₹7,441.07

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹1,595.80Fair value₹4,781.68Bull₹7,441.07

FairClose

52-week traded range

52W low ₹5,176.5052W high ₹5,422.50

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Dr. Agarwal'S Eye Hosp L closed at ₹5,306.00, 11.0% above the consensus fair value of ₹4,781.68 drawn from 8 valuation models.

Financial DNA score 59/100 — Good. P/E of 33.6x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹1,929.82

-63.6%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹1,595.80

-69.9%

√(22.5 × EPS × BVPS)

EPS=145.05, BVPS=780.29 · outside Graham range (P/E 33.6, P/B 6.8) — asset-light, treat as a rough floor

P/E Fair Value

₹7,441.07

+40.2%

EPS × 51.3x (sector P/E)

EPS=145.05, Sector P/E=51.3x

Peter Lynch (PEG)

₹3,292.64

-37.9%

EPS × Growth% (PEG = 1 is fair)

EPS=145.05, g=22.7%

EV/EBITDA

₹6,437.53

+21.3%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=1.91B

Book Value (P/B)

₹3,745.41

-29.4%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=780.29, ROE=25.2%, g=6%, r=10%

Reverse DCF

₹5,306.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 15.3% | Historical: 22.7%

Margin of Safety

₹2,741.67

-48.3%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=3655.56, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer